1. Home
  2. EDSA vs VMAR Comparison

EDSA vs VMAR Comparison

Compare EDSA & VMAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • VMAR
  • Stock Information
  • Founded
  • EDSA 2015
  • VMAR 1995
  • Country
  • EDSA Canada
  • VMAR Canada
  • Employees
  • EDSA N/A
  • VMAR N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • VMAR Marine Transportation
  • Sector
  • EDSA Health Care
  • VMAR Industrials
  • Exchange
  • EDSA Nasdaq
  • VMAR Nasdaq
  • Market Cap
  • EDSA 6.2M
  • VMAR 5.1M
  • IPO Year
  • EDSA N/A
  • VMAR 2020
  • Fundamental
  • Price
  • EDSA $2.36
  • VMAR $6.31
  • Analyst Decision
  • EDSA Strong Buy
  • VMAR Strong Buy
  • Analyst Count
  • EDSA 1
  • VMAR 1
  • Target Price
  • EDSA $21.00
  • VMAR $2,700.00
  • AVG Volume (30 Days)
  • EDSA 8.9K
  • VMAR 217.3K
  • Earning Date
  • EDSA 05-09-2025
  • VMAR 04-08-2025
  • Dividend Yield
  • EDSA N/A
  • VMAR N/A
  • EPS Growth
  • EDSA N/A
  • VMAR N/A
  • EPS
  • EDSA N/A
  • VMAR N/A
  • Revenue
  • EDSA N/A
  • VMAR $1,612,492.00
  • Revenue This Year
  • EDSA N/A
  • VMAR $120.43
  • Revenue Next Year
  • EDSA N/A
  • VMAR N/A
  • P/E Ratio
  • EDSA N/A
  • VMAR N/A
  • Revenue Growth
  • EDSA N/A
  • VMAR N/A
  • 52 Week Low
  • EDSA $1.55
  • VMAR $4.04
  • 52 Week High
  • EDSA $5.59
  • VMAR $1,039.50
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 51.83
  • VMAR 48.74
  • Support Level
  • EDSA $2.29
  • VMAR $5.83
  • Resistance Level
  • EDSA $2.40
  • VMAR $6.82
  • Average True Range (ATR)
  • EDSA 0.12
  • VMAR 0.71
  • MACD
  • EDSA 0.00
  • VMAR 0.16
  • Stochastic Oscillator
  • EDSA 87.88
  • VMAR 61.36

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About VMAR Vision Marine Technologies Inc.

Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.

Share on Social Networks: